false
Catalog
The Liver Meeting 2019
Hepatocellular Carcinoma Practice Guidance 2018
Hepatocellular Carcinoma Practice Guidance 2018
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript discusses the update of the HCC practice guideline and guidance, highlighting the importance of surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC). The guideline utilized the GRADE format and systematic reviews to address key questions on surveillance methods, lesion characterization, and treatment options based on disease stage. Recommendations include surveillance every six months with ultrasound or ultrasound plus AFP, considering CT or MR for lesion characterization, and favoring resection over ablation for early-stage HCC. The guidance also covers the role of adjuvant therapy, downstaging for transplantation, and various treatment options for different HCC stages, emphasizing the importance of a multidisciplinary approach. The ASLD recommends systemic therapy for advanced HCC patients and discusses new therapies available for treatment.
Asset Caption
Presenter: Julie Heimbach
Keywords
HCC practice guideline
surveillance methods
lesion characterization
treatment options
GRADE format
multidisciplinary approach
×
Please select your language
1
English